Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Food and Drug Administration (FDA)
Biotech
ASH 2025 marked by ‘enduring activism’ and ‘cautious optimism’
While references to the Trump administration's attacks on science were prominent, an optimistic ASH was all about the data—and puppies.
Darren Incorvaia
Dec 9, 2025 3:15pm
Yet another CDER leadership shake-up—Chutes & Ladders
Dec 5, 2025 8:30am
Denali ph. 1 Pompe plans hit with clinical hold
Dec 4, 2025 11:52am
CDER head Richard Pazdur retiring from FDA
Dec 2, 2025 12:55pm
FDA issues plan to reduce primate testing for certain antibodies
Dec 2, 2025 11:25am
FDA adopts agentic artificial intelligence in latest AI push
Dec 1, 2025 5:33pm
